<DOC>
	<DOCNO>NCT01252485</DOCNO>
	<brief_summary>This registry study adult patient newly diagnose refractory/relapsed myeloid neoplasm Investigator 's site : 60-70 site Germany Austria Estimated duration observation individual patient : 10 year maximum Objectives - To register patient acute myeloid leukemia relate precursor neoplasm , acute leukemia unambiguous lineage , high risk myelodysplastic syndrome ( MDS excess blast 2 ) , myeloid neoplasm germline predisposition , newly diagnose relapsed/refractory participate center ( completeness ) - To perform timely analysis disease-related genetic marker ( incidence , treatment recommendation ) - To assess patient family history , clinical characteristic outcome data ( event-free survival [ EFS ] , cumulative incidence relapse [ CIR ] , cumulative incidence death [ CID ] , overall survival [ OS ] ) - To assess biological disease feature correlate clinical outcome data ( prognostic predictive marker ) - To store biosamples patient ( e.g. , bone marrow , blood , plasma , normal tissue , e.g. , skin biopsy , buccal swap , finger nail , hair , sputum ) - To assess quality life</brief_summary>
	<brief_title>Registry Study Patient Characteristics , Biological Disease Profile Clinical Outcome Acute Myeloid Leukemia Related Neoplasms , Higher Risk Myelodysplastic Syndrome - The Biology Outcome ( BiO ) -Project</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<criteria>Patients suspect diagnosis AML relate precursor neoplasm , acute leukemias ambiguous lineage , high risk MDS ( MDS excess blast 2 [ MDSEB2 ] ) , myeloid neoplasm germline predisposition , newly diagnose relapsed/refractory , classify accord World Health Organization ( WHO ) classification Age â‰¥ 18 year . There upper age limit . Signed write informed consent Severe neurological psychiatric disorder interfere ability give inform consent No consent registration , storage process individual patient disease characteristic course well information family physician study participation No consent biobanking patient 's biological specimen performance analysis store material .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>AML</keyword>
	<keyword>Registry study</keyword>
	<keyword>Biology Outcome</keyword>
	<keyword>Higher Risk MDS</keyword>
</DOC>